COVID-19 vaccines saved 2.5 million lives in four years. They are among the most effective public health tools ever developed. Like undeserved heroes, vaccines protect even amid widespread scandal and misinformation.

Vaccine skepticism continues spreading across social media and online spaces. Some rumors claim COVID-19 vaccines cause serious long-term health harm. Current scientific consensus does not support those claims.

However, a new large study from France reveals strong benefits and no harm from COVID-19 mRNA vaccines. The national cohort study found no increase in all-cause mortality. Adults received COVID-19 vaccines up to four years earlier.

Vaccination reduced death from severe COVID-19 by 74%. The study also found a 25% percent reduction in all-cause mortality.

Results were published in JAMA Network Open.

[Read more…]

Fever acts like a locked vault that traps and destroys invaders. When pathogens enter, body temperature rises to eliminate threats. This defense mechanism evolved over millions of years. It remains one of the immune system’s first responses.

A newly discovered bird flu gene helps viruses survive fever. This finding raises serious concern among infectious disease scientists. If bird flu adapts for human transmission, fever may fail. That failure could dramatically worsen future pandemics.

Normal fevers usually stop human influenza viruses effectively. Bird flu viruses continue spreading despite elevated body temperatures. Fever normally shuts down viral replication. Bird flu appears able to resist this defense.

[Read more…]

Long COVID has few obvious links to other infectious diseases like tuberculosis. Yet, new research suggests hidden infections may activate alongside COVID-19. Viruses like Epstein-Barr could re-emerge as COVID-19 stresses immunity. This compound effect may explain fatigue, brain fog, and other Long COVID symptoms.

The study’s findings suggest coinfections may contribute to Long COVID development. These infections may exist before or emerge during COVID-19 infection. Their interaction with the immune system could drive persistent symptoms. This connection offers a new framework for understanding Long COVID mechanisms.

The study was published in eLife and led by 17 researchers. Many researchers involved were affiliated with Rutgers Health.

[Read more…]

Climate change expands tick ranges, so disease risks increase for everyone. Ticks spread several spotted fevers like Rocky Mountain spotted fever and rickettsial pox. These diseases all come from bacteria within the rickettsia genus. Rising tick movement now raises new concerns for animal and human health.

A new spotted fever organism recently killed multiple dogs in the United States. Researchers are watching this bacterium closely to prevent possible human transmission. Many rickettsia relatives can infect humans with serious disease. Experts say they should always be treated as potentially harmful.

North Carolina State University scientists cultured this new rickettsia bacterium from a sick dog. The dog showed symptoms similar to Rocky Mountain spotted fever infections. Sequencing revealed an entirely new species within the rickettsia lineage. Researchers named it Rickettsia finnyi after Finny, the infected dog.

An author of the study, Barbara Corollo, said this species first appeared in 2020. That early cluster involved three dogs with similar severe symptoms. She said 16 more dog samples have since tested positive. Most infections occurred across southeastern and midwestern states.

[Read more…]

The fall of Constantinople bears similarity to a surprising microscopic discovery. In some accounts, the Ottoman conquest succeeded when one gate was left open. That small mistake allowed invaders to enter the once-impregnable city. Some historians note the conquest may have hinged on that doorway.

Scientists see a similar pattern in recent flu research. High-resolution imaging shows flu viruses entering human cells in real time. These images reveal cells do not passively wait for infection. Instead, they sometimes help guide the virus inside.

Researchers from Switzerland and Japan built a bespoke microscopy system. Their tool zooms closely on the cell’s outer membrane in a dish. This system helps scientists watch flu viruses penetrate living cells. The work captures infection processes at extremely high resolution.

The results surprised the research team studying cell behavior. Cells did not remain dormant when the virus approached them. Instead, each cell seemed to reach out and actively grab the virus. Lead researcher Yohei Yamauchi described this moment as a “dance” between virus and cell.

[Read more…]

Common vaccines may help protect the aging brain. Recent studies found that shingles and RSV vaccines could lower dementia risk. A new study offers even stronger evidence supporting shingles vaccine dementia protection. These findings suggest that vaccines may offer a promising path for preventing the disease.

What Makes the Recent Findings Significant?

Research in NPJ Vaccines examined Shingrix and Arexvy, two vaccines that protect against shingles and RSV. The study found that both vaccines may also help reduce dementia risk. The researchers traced these protective effects to an immune-boosting adjuvant called AS01.

The study reported strong benefits for vaccinated people. Those who received the shingles vaccine showed an 18% lower dementia risk. The researchers believe AS01 plays a key role in strengthening immune memory. This connection may help protect the brain during aging.

However, the researchers noted major study limitations. People who choose vaccines are often healthier overall than those who decline. They may eat better diets and engage in more physical activity. These lifestyle factors strongly influence dementia risk, but rarely show up in medical records.

These hidden factors can create important confounding variables. They can make vaccines appear more protective than they actually are. Researchers needed a way to separate vaccine effects from everyday habits. That required a study design closer to a randomized controlled trial.

[Read more…]

A Washington State resident has died from H5N5 bird flu. This case marks the world’s first death from this rare strain and the first recorded human infection. Officials say the event highlights a new chapter in global bird flu surveillance.

The patient was older and had underlying health conditions. They had been hospitalized for an extended period before death, and state officials provided no further identifying details. Investigators are still reviewing the patient’s medical and exposure history.

The CDC confirmed the H5N5 infection and continues to classify the public risk as low. Officials say that no additional people have tested positive for bird flu. They also report no evidence of human-to-human transmission at this time.

Investigators say the patient was exposed by a backyard flock with mixed domestic bird species. Exposure to infected birds remains the most common source of transmission. Officials are monitoring nearby flocks to ensure no further spread occurs.

[Read more…]

Recent research shows that preventing RSV in newborns can prevent asthma. RSV infection early in life can raise long-term asthma risk. The effect is strongest in children with genetic allergy risks. Early RSV infections also push the immune system to overreact to allergens.

Newborns who receive preventative RSV medication develop asthma less often. These findings show another benefit of early RSV protection. They also highlight the importance of inoculating young children. Protecting newborns may reduce severe asthma across communities.

Researchers from Belgium and Denmark conducted this large study together. Teams from V.I.P. and Ghent University collaborated with Danish scientists. They published their results in Science Immunology. Their work addresses a major health burden.

Asthma affects 5–15% of European children today. This long-term illness harms daily well-being and family life. It also creates heavy financial strain for health systems. These challenges have pushed experts to pursue new prevention strategies.

[Read more…]

Vaccination has reduced measles deaths by 88% from 2000 to 2024. The World Health Organization (WHO) says almost 59 million lives were saved by the vaccine. Still, measles killed about 95,000 people in 2024. Most deaths occurred in children younger than five years old.

The 2024 statistic shows one of the lowest annual death totals since 2000. Yet every preventable death reflects a major global failure. This is especially tragic when a cheap and effective vaccine exists. Lower deaths also do not erase the reality of rising global measles cases.

Measles caused about 11 million infections in 2024. This number exceeds 2019 pre-pandemic records by almost 800,000 cases. The WHO’s Director-General, Dr. Tedros Adhanom Ghebreyesus, called measles the most contagious virus. He warned that any weakness in global defenses can be exploited quickly.

[Read more…]

A man joined his wife and children for a camping trip in summer 2024. The airline pilot and his family ate a late dinner at 10 p.m. They enjoyed beef steaks, even though the family usually consumed chicken. The night seemed normal until early morning.

The man woke at 2 a.m. with sudden and severe stomach pain. He writhed in bed while vomiting and having diarrhea. A few hours later, he felt better and slept through the night. He and his wife considered seeking medical advice but did not understand what happened.

Two weeks later, the man was back home in New Jersey. He and his wife attended a barbecue that afternoon. The man ate a hamburger at 3 p.m. and later mowed the lawn with no issues. His symptoms began at 7:20 p.m., and by 7:37 p.m., his son had called emergency services, but the man died three hours later.

His autopsy was inconclusive, but his wife sought definitive answers. She contacted her friend, Dr. Aaron McFeely, who reviewed the report and contacted Virginia researchers. Blood tests confirmed that the man had alpha-gal syndrome from a lone star tick bite, marking the first confirmed fatal transmission of this allergy. Researchers say this case shows why broader awareness of alpha-gal risks is urgently needed.

[Read more…]